Sort
40,608 grants matching “prostate cancer”
Molecular Profiling of Clinical Specimens
$1,874,339Daniel Edelman · Division Of Basic Sciences - Nci · ZIC · FY2012 · CA
Center for Transformative Community-Driven Research to Prevent Obesity-related Cancer
$1,872,858Karen M Basen-Engquist · University Of Tx Md Anderson Can Ctr · U54 · FY2024 · CA
SELISISTAT AS AN ANTI-PROSTATE CANCER AGENT FOR TREATMENT OF PROSTATE CANCER
$1,872,750The University Of Texas Health Science Center At San Antonio · · FY2025 · Defense Health Agency
SPORE In Prostate Cancer
$1,871,390Howard I Scher · Sloan-Kettering Inst Can Research · P50 · FY2013 · CA
Northwestern Cancer Prevention Consortium
$1,870,000Seema Ahsan Khan · Northwestern University At Chicago · UG1 · FY2025 · CA
GENERAL CLINICAL RESEARCH CENTER
$1,869,281University Of Iowa · M01 · FY2000 · RR
Harvard Transdisciplinary Research in Energetics and Cancer Center
$1,866,635Frank B Hu · Harvard School Of Public Health · U54 · FY2012 · CA
PROSTATE CANCER CLINICAL TRIALS CONSORTIUM: UNIVERSITY OF WISCONSIN
$1,865,644University Of Wisconsin System · · FY2022 · Defense Health Agency
DNA Sequencing
$1,865,206Trevor K Archer · National Institute Of Environmental Health Sciences · ZIC · FY2017 · ES
Genetics of Prostate Cancer in Africa
$1,863,488Timothy R Rebbeck · Dana-Farber Cancer Inst · U01 · FY2015 · CA
IGF::OT::IGF CORE INFRASTRUCUTE SUPPORT FOR SURVEILLANCE, EPIDEMIOLOGY, AND END RESULTS (SEER) STUDY PERIOD OF PERFORMANCE 05/01/2015-04/30/2016
$1,861,162Carol Sweeney · University Of Utah · N01 · FY2015 · CA
Genetic Variation in Cancer Risk and Outcomes in African Americans
$1,860,121Ann G Schwartz · Wayne State University · P01 · FY2025 · CA
COHORT STUDY OF DIETARY SUPPLEMENTS AND CANCER RISK
$1,859,452Fred Hutchinson Cancer Research Center · R01 · FY2000 · CA
Clinical and Immunologic Evaluation of ProstAtak for Prostate Cancer
$1,857,725Estuardo Aguilar-Cordova · Advantagene, Inc · R44 · FY2013 · CA
DNA Sequencing and FACS Core Facilities
$1,856,446Paul Robbins · Division Of Basic Sciences - Nci · Z01 · FY2008 · CA
Center for Cancer Nanotechnology Excellence for Translational Diagnostics (CCNE-TD)
$1,854,519Sanjiv S Gambhir · Stanford University · U54 · FY2015 · CA
ROLE OF TBX2 IN THE ESTABLISHMENT OF THE PROSTATE CANCER PREMETASTATIC NICHE (PMN) IN THE BONE
$1,854,473Texas Tech University Health Sciences Center · · FY2025 · Defense Health Agency
THE ROLE OF PTEN AND THE PI3K PATHWAY IN PROSTATE CANCER
$1,853,371Beth Israel Deaconess Medical Center · P01 · FY2002 · CA
Clinical Cancer Genomics Program
$1,853,306Kathleen Calzone · Division Of Basic Sciences - Nci · ZID · FY2024 · CA
An Extensible Resource for Genomic Analysis and Petascale Storage
$1,849,685Harel Weinstein · Weill Medical Coll Of Cornell Univ · S10 · FY2012 · OD
VITamin D and omegA-3 triaL (VITAL)
$1,849,394Joann Elisabeth Manson · Brigham And Women'S Hospital · U01 · FY2014 · CA
THE ROLE OF PTEN AND THE PI3K PATHWAY IN PROSTATE CANCER
$1,848,666Beth Israel Deaconess Medical Center · P01 · FY2001 · CA
MSKCC CENTER FOR IN VIVO MOLECULAR IMAGING IN CANCER
$1,848,429Sloan-Kettering Institute For Cancer Res · P50 · FY2005 · CA
THERAPEUTIC TARGETING OF ABERRANT MRNA POLYADENYLATION IN LETHAL PROSTATE CANCER
$1,848,000Regents Of The University Of Minnesota · · FY2025 · Defense Health Agency
Core B: Recruitment and Sample Collection
$1,847,906Ann S Hamilton · University Of Southern California · U19 · FY2019 · CA